A more efficient conditional mouse model of Dravet syndrome: Implications for epigenetic selection and sex-dependent behaviors

Autor: Williams, Aaron D. ^{a, 1}, Kalume, Franck ^{a, b, c}, Westenbroek, Ruth E. ^a, Catterall, William A. ^{a, ⁎}

Publikováno v: In Journal of Neuroscience Methods 1 September 2019 325

Guidelines for Return to Duty (Play) After Heat Illness: A Military Perspective.

Autor: O'Connor, Francis G., Williams, Aaron D., Blivin, Steve, Heled, Yuval, Deuster, Patricia, Flinn, Scott D.

Publikováno v: Journal of Sport Rehabilitation; Aug2007, Vol. 16 Issue 3, p227-237, 11p, 1 Diagram, 2 Charts, 2 Graphs

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Molecular Pharmacology of Selective Na V 1.6 and Dual Na V 1.6/Na V 1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo.

Autor: Goodchild SJ; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Shuart NG; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Williams AD; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Ye W; Neurocrine Biosciences, San Diego, California 92130, United States., Parrish RR; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Soriano M; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Thouta S; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Mezeyova J; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Waldbrook M; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Dean R; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Focken T; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Ghovanloo MR; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada.; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.; Department of Neurology, Yale University, New Haven, Connecticut 06519, United States., Ruben PC; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada., Scott F; Neurocrine Biosciences, San Diego, California 92130, United States., Cohen CJ; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Empfield J; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada., Johnson JP; Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2024 Mar 20; Vol. 15 (6), pp. 1169-1184. Date of Electronic Publication: 2024 Feb 15.